Joanalyn Bartolome

Joanalyn Bartolome is a seasoned Senior Scientist with extensive experience in neuroimmunology and immuno-oncology. Currently employed at Neurocrine Biosciences, Joanalyn has a history of pivotal contributions across several organizations. At Replay, Joanalyn established immune cell-based assays for iPSC-derived NK cells, while at Fate Therapeutics Inc, Joanalyn generated potency assays for HER2 CAR-mediated cytotoxicity in T-cells. Previous roles at Pfizer included leading and training teams in developing preclinical assays and enhancing therapies for hematological malignancies, in addition to contributing to oncolytic vaccine research. Early career experience involves roles at Biosite Diagnostics, Ligand Pharmaceuticals, The Scripps Research Institute, and the VA Medical Center, supplemented by a foundational education at San Diego State University.